( December 11, 2025, 8:49 AM EST) -- NEWARK, N.J. — A man who alleges that his use of Dupixent, a prescription medication used for the treatment of asthma and inflammatory skin conditions, caused him to develop cutaneous T-cell lymphoma (CTCL), a rare type of cancer that affects white blood cells called T cells, or T lymphocytes, sued the manufacturers in a New Jersey federal court....